JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 10 November 2006. doi:10.1136/jnnp.2006.103788
Journal of Neurology, Neurosurgery, and Psychiatry 2007;78:819-824
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnnp.2006.103788v1
78/8/819    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haaxma, C. A
Right arrow Articles by Horstink, M. W I M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haaxma, C. A
Right arrow Articles by Horstink, M. W I M
Related Collections
Right arrowRelated Article

PAPER

Gender differences in Parkinson’s disease

Charlotte A Haaxma1, Bastiaan R Bloem1, George F Borm2, Wim J G Oyen3, Klaus L Leenders4, Silvia Eshuis4, Jan Booij5, Dean E Dluzen6, Martin W I M Horstink1

1 Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
2 Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
3 Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
4 Department of Neurology, Groningen University Medical Centre, Groningen, the Netherlands
5 Department of Nuclear Medicine, Academic Medical Centre, Amsterdam, the Netherlands
6 Department of Anatomy, Northeastern Ohio Universities, College of Medicine, Rootstown, Ohio, USA

Correspondence to:
Correspondence to:
Dr Bastiaan R Bloem
Department of Neurology (935), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, the Netherlands; b.bloem{at}neuro.umcn.nl

Objective: To investigate gender differences in basic disease characteristics, motor deterioration and nigrostriatal degeneration in Parkinson’s disease (PD).

Methods: We studied 253 consecutive PD patients who were not receiving levodopa or dopamine agonists (disease duration <=10 years). We investigated the influence of gender and oestrogen status on: (1) age at onset, (2) presenting symptom, (3) severity and progression of motor symptoms (Unified Parkinson’s Disease Rating Scale III (UPDRS-III) scores) and (4) amount and progression of nigrostriatal degeneration ([123I]FP-CIT single photon emission computed tomography measurements).

Results: Age at onset was 2.1 years later in women (53.4 years) than in men (51.3 years). In women, age at onset correlated positively with parity, age at menopause and fertile life span. Women more often presented with tremor (67%) than men (48%). Overall, patients presenting with tremor had a 3.6 year higher age at onset and a 38% slower UPDRS-III deterioration. Mean UPDRS-III scores at disease onset were equal for both genders, as was the rate of deterioration. Women had a 16% higher striatal [123I]FP-CIT binding than men at symptom onset and throughout the course of PD.

Conclusions: Our results suggest that, in women, the development of symptomatic PD may be delayed by higher physiological striatal dopamine levels, possibly due to the activity of oestrogens. This could explain the epidemiological observations of a lower incidence and higher age at onset in women. Women also presented more often with tremor which, in turn, is associated with milder motor deterioration and striatal degeneration. Taken together, these findings suggest a more benign phenotype in women with PD.


Abbreviations: PD, Parkinson’s disease; SPECT, single photon emission computed tomography; sUPDRS-III, selection of items of the Unified Parkinson’s Disease Rating Scale III; UPDRS-III, Unified Parkinson’s Disease Rating Scale III


Related Article

Sex and Parkinson’s disease: a world of difference?
David J Burn
J. Neurol. Neurosurg. Psychiatry 2007 78: 787. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Menopause IntHome page
M. D. Price and L. M Shulman
Management of Parkinson's disease in older women
Menopause Int, March 1, 2008; 14(1): 38 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D. J Burn
Sex and Parkinson's disease: a world of difference?
J. Neurol. Neurosurg. Psychiatry, August 1, 2007; 78(8): 787 - 787.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.